Skip to main content
PMCB
NASDAQ Life Sciences

PharmaCyte Sets Reverse Stock Split as Nasdaq $1 Bid Deadline Looms

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.415
Mkt Cap
$4.317M
52W Low
$0.302
52W High
$1.51
52W Position info
37% above low
Off High info
73% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

PMCB sits 37% above its 52-week low of $0.302.

Summary

PharmaCyte's board approved a 1-for-19 reverse stock split, a mechanical share-count change aimed squarely at the Nasdaq $1.00 minimum bid requirement it must meet by November 30. The stock last traded around $0.41, so a reverse split is the standard route to lift the quoted price above the threshold. This comes after a rough stretch: the September 10-Q showed a $5.08 million quarterly loss and material weaknesses in financial controls, and the company swapped auditors in October, dismissing CBIZ and engaging Grassi effective October 14, 2026. The split itself creates no value — it only resets the share count and price — but it is the company's main lever to avoid delisting. Watch whether the post-split price holds above $1.00 through the November 30 deadline.

At the time of this announcement, PMCB was trading at $0.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $0.30 to $1.51. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PMCB - Latest Insights

PMCB
Oct 16, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3402
Real-time Price: $0.3222 info
Change: -$0.018 (-5%) info
Market Cap: $4.317M info
PMCB
Sep 14, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.392
Real-time Price: $0.3222 info
Change: -$0.0698 (-18%) info
Market Cap: $4.317M info
PMCB
Apr 02, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.720
Real-time Price: $0.3222 info
Change: -$0.3978 (-55%) info
Market Cap: $4.317M info
PMCB
Mar 17, 2026, 3:49 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.6957
Real-time Price: $0.3222 info
Change: -$0.3735 (-54%) info
Market Cap: $4.317M info
PMCB
Mar 09, 2026, 6:02 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.7854
Real-time Price: $0.3222 info
Change: -$0.4632 (-59%) info
Market Cap: $4.317M info